May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 16, 2025

Long-Term Data Support BCT for BRCA-Mutated Breast Cancer

Researchers found that breast-conserving treatment provided long-term survival outcomes comparable to mastectomy in patients with breast cancer and BRCA1 or BRCA2 pathogenic variants.

Conexiant

May 16, 2025

Removing NET on MRI Extends Glioblastoma Survival

A new multinational study found that removing the full extent of noncontrast-enhanced tumor seen on MRI scans led to significantly longer survival in patients with IDH wild-type glioblastoma.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 15, 2025

Considering Positive Spherical Aberration

Positive SA is a patient-friendly approach to extending depth of focus, writes Kendall E. Donaldson

The Ophthalmologist

May 14, 2025

Enabling Early Intervention with Complete Control

Glaucoma specialist Inder Paul Singh outlines the precision and versatility of the VIA360™ Surgical System for the delivery of viscoelastic fluid during ophthalmic surgery

The Ophthalmologist

May 14, 2025

Pneumomediastinum After Dental Cleaning: What's Your Diagnosis?

A rare case of pneumomediastinum and subcutaneous emphysema following dental cleaning requires high-flow oxygen therapy rather than invasive interventions. Learn why.

Conexiant

May 14, 2025

Leading Cause of Death in Residents, Study

Study shows high suicide rates during training transitions, with pathology residents facing the highest suicide risk compared with other specialties.

Conexiant

May 13, 2025

GLP-1s May Protect Against Obesity-Related Cancer

First-generation GLP-1 receptor agonists provide comparable protection against obesity-related cancers as bariatric surgery.

Conexiant